Zobrazeno 1 - 10
of 1 679
pro vyhledávání: '"Oligometastasis"'
Autor:
Vasiliy I. Egorov, Aleksey G. Kotelnikov, Yury I. Patyutko, Danil V. Podluzhny, Alexandr N. Polyakov, Nikolai E. Kudashkin, Albert N. Daminov
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 52, Iss 5, Pp 249-258 (2024)
Background: New chemotherapy regimens (gemcitabine / nab-paclitaxel, FOLFIRINOX) have improved overall survival rates in ductal carcinoma, which has renewed the interest in surgical treatment for isolated liver metastases. Aim: To identify the rol
Externí odkaz:
https://doaj.org/article/ce0b35b9eb204a8d914d173751fcad25
Autor:
Sebastian M. Christ, Gabriel W. Thiel, Philip Heesen, Siyer Roohani, Michael Mayinger, Jonas Willmann, Maiwand Ahmadsei, Urs J. Muehlematter, Alexander Maurer, Josef A. Buchner, Jan C. Peeken, Rifaquat Rahman, Ayal Aizer, Emilie Le Rhun, Nicolaus Andratschke, Michael Weller, Martin Huellner, Matthias Guckenberger
Publikováno v:
Radiation Oncology, Vol 19, Iss 1, Pp 1-10 (2024)
Abstract Background and introduction Increasing evidence suggests that a subgroup of patients with oligometastatic cancer might achieve a prolonged disease-free survival through local therapy for all active cancer lesions. Our aims are to investigate
Externí odkaz:
https://doaj.org/article/ff7a943679364d83a351928248cf211e
Publikováno v:
ImmunoTargets and Therapy, Vol Volume 13, Pp 447-459 (2024)
Murong Wang,1,* Qunfang Zhou,2,* Hui Li,1 Mingyu Liu,3 Ruixia Li,4 Wei Wang,5 Xiaohui Wang,6 Jinhua Huang,1 Feng Duan2 1Department of Minimally Invasive Interventional Radiology, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong prov
Externí odkaz:
https://doaj.org/article/1e0f6c72b2cf4b8dbb638abac4766c3e
Autor:
Abhishek A. Solanki, Kevin Zheng, Alicia N. Skipworth, Lisa M. Robin, Ryan F. Leparski, Elizabeth Henry, Matthew Rettig, Joseph K. Salama, Timothy Ritter, Jeffrey Jones, Marcus Quek, Michael Chang, Alec M. Block, James S. Welsh, Aryavarta Kumar, Hann-Hsiang Chao, Albert C. Chen, Ronald Shapiro, Rhonda L. Bitting, Robert Kwon, William Stross, Lindsay Puckett, Yu-Ning Wong, Nicholas G. Nickols, Kimberly Carlson
Publikováno v:
Current Oncology, Vol 31, Iss 8, Pp 4781-4794 (2024)
The United States Veterans Affairs (VA) Health Care System has a strong history of conducting impactful oncology randomized clinical trials (RCTs). We developed a phase II/III RCT to test the use of metastasis-directed therapy in Veterans with oligom
Externí odkaz:
https://doaj.org/article/4a86707c77484767b9eb8ec89a024ca0
Autor:
Mohan Hingorani, Hannah Stubley
Publikováno v:
Exploration of Targeted Anti-tumor Therapy, Vol 5, Iss 4, Pp 921-930 (2024)
The prognosis of metastatic esophageal cancer (EC) remains poor with an average life expectancy of around 9–12 months with standard systemic chemotherapy. The concept of oligometastatic disease (OMD) in EC cancer is controversial with no universall
Externí odkaz:
https://doaj.org/article/9cff5f06fc0f47d0bb093678c61711a2
Autor:
Kana Hashimoto, MD, Daisuke Morinaga, MD, Hajime Asahina, MD, PhD, Mina Ishidoya, MD, Hajime Kikuchi, MD, PhD, Hiroshi Yokouchi, MD, PhD, Toshiyuki Harada, MD, PhD, Osamu Honjo, MD, Ryota Shigaki, MD, Taichi Takashina, MD, PhD, Yuka Fujita, MD, PhD, Mamoru Takahashi, MD, PhD, Yasutaka Kawai, MD, Ryotaro Kida, MD, Kenichiro Ito, MD, Noriaki Sukoh, MD, PhD, Ayumu Takahashi, MD, PhD, Fumihiro Hommura, MD, PhD, Yoshihito Ohhara, MD, PhD, Megumi Furuta, MD, PhD, Satoshi Konno, MD, PhD, Yukio Hosomi, MD, PhD, Satoshi Oizumi, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 5, Iss 11, Pp 100715- (2024)
Introduction: Oligometastasis and oligoprogression (OP) has not been adequately defined in extensive-stage SCLC (ES-SCLC) and may be a good indication for adding local treatment. Therefore, this multicenter study aimed to investigate the prognostic i
Externí odkaz:
https://doaj.org/article/6a9e9af6ebb84315b50bcf56a349d75d
Autor:
Gyu Sang Yoo, Sunmin Park, Chai Hong Rim, Won Kyung Cho, Ah Ram Chang, Young Seok Kim, Yong Chan Ahn, Eui Kyu Chie
Publikováno v:
Current Oncology, Vol 31, Iss 6, Pp 3239-3251 (2024)
Background: Interest in the oligometastatic prostate cancer (OMPC) is increasing, and various clinical studies have reported the benefits of metastasis-directed radiation therapy (MDRT) in OMPC. However, the recognition regarding the adopted definiti
Externí odkaz:
https://doaj.org/article/b0e0ff83c6a348c08c50fc4380a7237f
Autor:
Ryo Saito, Daisuke Ban, Takahiro Mizui, Takeshi Takamoto, Satoshi Nara, Minoru Esaki, Kazuaki Shimada
Publikováno v:
Annals of Gastroenterological Surgery, Vol 8, Iss 3, Pp 481-489 (2024)
Abstract Purpose Whether surgical intervention for patients with oligometastatic recurrence can improve their post‐recurrent prognosis is unclear. In this study, we introduce a novel concept of oligometastasis in post‐surgical pancreatic ductal a
Externí odkaz:
https://doaj.org/article/62c2e38a3840421f846722042d7cae45
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Background The treatment for lung oligometastasis from colorectal cancer (CRC) remains challenging. This retrospective study aimed to compare the local tumor control, survival and procedure-related complications in CRC patients undergoing lo
Externí odkaz:
https://doaj.org/article/34d9119bf68d4c67be46823fbb1af3f6
Autor:
Meiko Morita, Akira Ono, Motoki Sekikawa, Kosei Doshita, Keita Miura, Hiroaki Kodama, Michitoshi Yabe, Noboru Morikawa, Yuko Iida, Nobuaki Mamesaya, Haruki Kobayashi, Ryo Ko, Kazushige Wakuda, Hirotsugu Kenmotsu, Tateaki Naito, Haruyasu Murakami, Mitsuhiro Isaka, Yasuhisa Ohde, Toshiaki Takahashi
Publikováno v:
Cancer Reports, Vol 7, Iss 9, Pp n/a-n/a (2024)
ABSTRACT Background Mutations in the epidermal growth factor receptor (EGFR) gene are the most common targetable gene alterations in non‐small cell lung cancer (NSCLC). In Japan, approximately 40% of patients who undergo surgical resection for non
Externí odkaz:
https://doaj.org/article/3c7205c59c0848928a7fc40d19564462